Ergomed saw no growth in patent filings and highest growth of 0.49% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Ergomed’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Ergomed has been focused on protecting inventions in Spain(ES) with one publication in Q2 2024
The Spain(ES) Patent Office dominates the patent grants with nearly 100% of grants. The Spain(ES) patent Office are among the top ten patent offices where Ergomed is filings its patents. Among the top granted patent authorities, Ergomed has 100% of its grants in Spain(ES).
Zhejiang University and Johnson & Johnson could be the strongest competitors for Ergomed
Patents related to rare diseases lead Ergomed's portfolio
Ergomed has the highest number of patents in rare diseases. For rare diseases no patents were filed and 100% of patents were granted in Q2 2024.
Wounds related patents lead Ergomed portfolio followed by bleeding and clotting disorders, and hemorrhage
Ergomed has highest number of patents in wounds followed by bleeding and clotting disorders, hemorrhage, hemostasis.
For comprehensive analysis of Ergomed's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
